Tocilizumab in Refractory Rheumatoid Arthritis: Long-Term Efficacy, Safety, and Tolerability Beyond 2 Years
Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.s101289
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2016
Authors
Publisher
Informa UK Limited